A Non-Interventional Safety Study of Balsamic Bactrim
Status:
Completed
Trial end date:
2017-07-31
Target enrollment:
Participant gender:
Summary
This is a pilot, observational and multicentric study of safety of sulfamethoxazole +
trimethoprim + guaifenesin (Balsamic Bactrim) in adult participants with acute bronchitis.
Adult participants with acute bronchitis eligible for treatment with Balsamic Bactrim will be
enrolled. Administration of Balsamic Bactrim will be according to physician's recommendation
under local labeling.
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination Guaifenesin Phenylpropanolamine Sulfamethoxazole Trimethoprim Trimethoprim, Sulfamethoxazole Drug Combination